CUL4B and neoplasm: In vivo tumour formation assay also found that after CUL4B knockdown, the tumour was composed of significantly more epithelial cells than mesenchymal cells (Figure 7B–D), showing that CUL4B can affect EMT and thereby affect drug resistance.